25/06/2025
WEIGHT LOSS MEDICATION
We are noticing a surge in requests for weight-loss medication, following announcements in the media on 23rd June that these medications are now "available on the NHS."
Please can we ask patients NOT to contact your GP to enquire whether you are eligible as these medications will not be available in Derby and Derbyshire until later in the year.
In addition, once the referral pathways in Derbyshire have been opened, there are strict eligibility criteria we must stick to. Eligibility for referral will be opened up in phases over the next 3 years.
In Phase 1 (2025-26), patients must have a BMI (Body Mass Index) of 40 or more AND at least four of the following diagnosed health conditions:
✓ type 2 diabetes
✓ high blood pressure
✓ heart disease
✓ obstructive sleep apnoea
✓ abnormal blood fats (dyslipidaemia)
The number of patients eligible for referral in phase one are expected to be very small.
If you are struggling with your weight and would like support, you can self-refer to Live Life Better Derbyshire who offer a range of weight-loss support services. They will also be able to refer eligible patients for weight loss medications once these become available in Derbyshire. You do not need to contact your GP Practice to access these services.
https://www.livelifebetterderbyshire.org.uk/home.aspx
More information on Derbyshire's plans to roll out weight-loss medications can be found here: https://joinedupcarederbyshire.co.uk/stay-well/tirzepatide/
This information is about how the weight loss drug tirzepatide (Mounjaro®) will be prescribed to patients.